Press Releases

Fontem Ventures Welcomes Lancet Article On Greater EVP Debate

29.01.15

Fontem Ventures is agrees with the article calling for a more inclusive debate regarding EVPs though calls for a distinction to be made between EVPs and tobacco containing products.

Fontem Ventures welcomes the article in The Lancet calling for a more inclusive debate regarding Electronic Vaping Products.We understand that regulating EVPs is a challenge for the Government because it is a new category.  What is important is that we look at the big picture and assess the overall impact on society; and then create a regulatory framework that works for consumers. One thing is clear however.  Governments needs to create a clear distinction between those products like EVPs that do not contain tobacco on the one hand, and all those traditional or new products that do contain tobacco on the other.  This should be the basis for all regulatory actions. We would welcome the opportunity to meet with regulators to ensure that consumers are given clear signals – in taxation, accessibility and conditions of use.

Click here to read the article in The Lancet.

blu was founded in the USA in 2009 and is one of the original e-cigarette brands. It was acquired by Fontem Ventures in 2015. As one of the world’s most recognizable vape brands, blu offers adult smokers’ choice through high-quality e-vapour products and e-liquids.

Nerudia was established in 2013 and became part of Imperial Brands in 2017. It is the home of innovation and technology R&D for Next Generation Products (NGP) which includes e-vapour, heated tobacco and oral nicotine delivery. Nerudia is dedicated to creating a world where smokers have choice.

Fontem Ventures is a subsidiary of Imperial Brands PLC, a global consumer organisation and the fourth largest international tobacco company in the world, operating across 120 markets.

[contact-form-7 404 "Not Found"]